Indian-Run Kusum Group Pharma Plant in Ukraine Destroyed in Russian Drone Attack; One Killed

An Indian-run pharmaceutical manufacturing facility in Ukraine’s northeastern city of Sumy has been largely destroyed following Russian drone attacks, leaving one person dead and several others injured. The plant belongs to the Kusum Group, an India-founded pharmaceutical business with significant operations in Ukraine. The incident represents a major setback for the company, which had continued manufacturing in the country despite the ongoing Russia-Ukraine conflict.

The attack caused extensive damage to the facility’s main structure. Images from the site showed a large plume of smoke rising from the area after the drones struck. Officials indicated that casualty figures could change as emergency response and assessment operations continued.

The financial impact is also expected to be substantial. Initial estimates put the damage to the Sumy facility at at least ₹400 crore, although a detailed assessment may be required to establish the full extent of the losses.

Kusum Group’s Manufacturing Operations in Ukraine

The Kusum Group began its business in 1994 by exporting Indian medicines to Ukraine. Over time, it moved beyond distribution and developed its own pharmaceutical brands before entering manufacturing.

The company established a production facility in Sumy in 2009, adding to its manufacturing presence in India. Its business includes generic medicines and products supplied to markets such as Ukraine, Uzbekistan, Kazakhstan and the Philippines.

Kusum has described itself as a Ukrainian pharmaceutical company with Indian roots. Its operations in Ukraine continued during the years of conflict, making the destruction of the Sumy plant particularly significant for its manufacturing network.

The company’s official profile identifies Sumy as one of its production locations. The facility’s damage could therefore affect its production capacity, although the immediate impact on individual medicines and supply arrangements has not been publicly confirmed.

One Person Killed, Several Injured

The drone attack resulted in one confirmed death, while several people sustained injuries. Authorities have indicated that the number of casualties may be revised as more information becomes available.

The incident highlights the risks faced by businesses and workers operating in areas affected by the war. Industrial and commercial facilities have also faced disruption as attacks continue to affect different parts of Ukraine.

The full circumstances surrounding the strike, including the extent of damage to surrounding infrastructure, remain subject to further assessment.

Possible Impact on Pharmaceutical Supply

The destruction of a manufacturing facility can create challenges beyond the immediate financial loss. Production schedules, storage, distribution and supply commitments may all be affected when a major plant becomes inoperable.

However, it is too early to determine whether the attack will lead to shortages of specific medicines. The company’s other facilities and existing distribution arrangements may help maintain supplies, but no detailed recovery plan has been announced publicly.

The incident also raises questions about how pharmaceutical companies can protect essential manufacturing operations during prolonged conflict. Medicine production depends on stable infrastructure, trained employees, reliable logistics and access to raw materials—all of which can be disrupted by war.

A Major Setback Amid the Ongoing War

For Kusum Group, the loss of its Sumy facility is both a humanitarian and business setback. The death and injuries reported in the attack underline the human cost, while the estimated financial damage points to the scale of the industrial loss.

As the situation develops, attention will turn to the company’s plans for restoring production and maintaining medicine supplies. Any confirmed update on the facility’s reconstruction or operational recovery will be important for employees, customers and the wider pharmaceutical sector.